Testing effectiveness (Phase 2)UnknownNCT02588131
What this trial is testing
Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)
Who this might be right for
Pleural MesotheliomaPeritoneal Mesothelioma
Italian Network for Tumor Biotherapy Foundation 40